臨床意思決定支援システム (CDSS) 市場 : 2028年までの世界予測

Report Overview

The global clinical decision support systems (CDSS) market is projected to reach USD 2.5 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 7.5% during the forecast period. The growth of this market is primarily driven by the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders, rising incidence of medication errors, and the development mHealth and big data tools.
However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.

“Software segment is expected to grow at the highest rate from 2023 to 2028”
By component, the clinical decision support systems market is divided into  services, software, and hardware. The services segment accounted for the largest share of this market in 2022 The demand for services is expected to grow rapidly in the coming years due to the introduction of complex software, integration, and software interoperability, which requires extensive training and upgrades.

“The On-premise CDSS  segment is estimated to account for the largest share of the Clinical decision support systems market in 2023”
By delivery mode, the clinical decision support systems market is divided into  on-premise and cloud-based modes. In 2023, the on-premise CDSS segment is projected to hold the largest share of the clinical decision support systems market.Factors such as  lower capital expenses and operational costs incurred in this model, together with its scalability, flexibility, and low-cost are  driving the market growth.

“In 2022, conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market, by application”
By application, the clinical decision support systems market is divided into conventional CDSS and advanced CDSS. The conventional CDSS segment accounted for the largest share of the market in 2022. Factors such as  healthcare organizations are adopting conventional decision support systems to provide guidance and reminders to caregivers at the point-of-care are  driving the market growth.

“In 2022, Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market”
By product, the clinical decision support systems market is divided into integrated CDSS and standalone CDSS. The integrated CDSS segment accounted for the largest share of the market in 2022. The large share of this segment can be attributed to the reduce medication errors by healthcare providers and increased usage of integrated CDSS to improve the health outcomes and quality of care .
“The therapeutic CDSS segment  is expected to grow with the highest CAGR  from 2023 to 2028”
By type, the clinical decision support systems market is divided into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2022 This highest growth rate of this segment can be attributed to factors such as  as therapeutic CDSS is equipped with a high computational capacity and a wealth of medical knowledge, making it plausible for clinicians to make informed therapeutic decisions (based on patient-specific medical facts).
“Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market, by model”
The clinical decision support systems market is categorized into two main models: knowledge-based CDSS and non-knowledge-based CDSS. In 2022, the knowledge-based CDSS segment held the largest market share. This particular segment is projected to experience substantial growth throughout the forecast period. This growth can be attributed to the escalating need for personalized and evidence-based medicine, alongside the growing prevalence of chronic ailments.

“The Active CDSS segment  is expected to grow with the highest CAGR  during the forecast period”

The clinical decision support systems market can be categorized based on interactivity level into active CDSS and passive CDSS. In 2022, the active CDSS segment dominated the market share, and it is anticipated to exhibit the most rapid growth rate during the forecast period. Strong governmental efforts aimed at fostering clinical IT solutions, including EHR, CDSS, and CPOE, along with the increasing imperative to control healthcare expenditures, contribute to the advancement of this specific market segment.

“Inpatient settings accounted for the largest share of the global Clinical decision support systems market in 2022”
In terms of setting, the clinical decision support systems market is categorized into inpatient and ambulatory care settings. In 2022, the inpatient settings dominated the CDSS market share. This dominance can be attributed to the substantial accumulation and analysis of extensive patient data within inpatient settings, consequently driving the heightened uptake of integrated healthcare IT modules.

“North America  to dominate the Clinical decision support systems market in 2023”
North America accounted for the largest share of the global clinical decision support systems market in 2022.
Elements including the existence of major industry participants, regulatory directives that support CDSS adoption, and the rise in medication errors in the US and Canada contribute to these trends.
Forecasts indicate that the Asia Pacific region will witness the most significant compound annual growth rate (CAGR) throughout the projected timeframe. This is due to factors such as the escalating prevalence of chronic illnesses and the growing attention of diverse market stakeholders toward emerging Asian nations. These factors are anticipated to propel the expansion of the clinical decision support systems market in the Asia Pacific region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
• By Designation: C-level (26%), Director-level (17%), and Others (57%)
• By Region: North America (40%), Europe (20%), Asia Pacific (30%), and Latin America (6%), MEA(4%)

Prominent players operating in the clinical decision support systems market are Wolters Kluwer N.V. (Netherlands), Oracle (US), Merative (US), Change Healthcare (US), Veradigm Inc. (US), athenahealth (US), Epic Systems Corporation (US), Elsevier B.V. (Netherlands), Zynx Health (US), Koninklijke Philips N.V. (Netherlands), Medical Information Technology, Inc. (US), NextGen Healthcare, Inc. (US), CureMD Healthcare (US), Siemens Healthineers (Germany), EBSCO Information Services (US), GE HealthCare (US), eClinicalWorks (US), The Medical Algorithms Company (UK), RAMPmedical (Germany), Hera-MI (France), CareCloud, Inc. (US), VisualDx (US), Premier, Inc. (US), First Databank, Inc. (US), and Strata Decision Technology (US).
Research Coverage
• The report studies the Clinical decision support systems market based on component, delivery mode, product, model, interactivity level, application, setting, type, and region 
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Clinical decision support systems market
• The report forecasts the revenue of market segments with respect to four major regions
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
§ Analysis of key drivers (implementation of government regulations & initiatives to promote the adoption of HCIT solutions, increasing adoption of cdss-enabled ehrs,growing collaborations & partnerships between stakeholders, growing incidence of medication errors ,development of big data and mhealth tools), restraints (data security concerns related to cloud-based cdss, inadequate interoperability), opportunities (growth potential of emerging markets, social media integration and rising technological advancements), challenges (requirement of high investments for the implementation of CDSS infrastructure ,shortage of skilled IT professionals in the healthcare industry).

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global Clinical decision support systems Market. The report analyzes this market by component, delivery mode, product, model, interactivity level, application, setting, type.
• Service Enhancement/Innovation: Detailed insights on upcoming trends in the global Clinical decision support systems
• Market Development: Comprehensive information on the lucrative emerging markets by component, delivery mode, product, model, interactivity level, application, setting, type.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global Clinical decision support systems Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Clinical decision support systems Market. 

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 36
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
FIGURE 1 CDSS MARKET SEGMENTATION 37
1.3.2 REGIONS COVERED 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 38
1.5 MAJOR STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 39
1.7 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 2 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY RESEARCH 42
FIGURE 3 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 44
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
2.2 MARKET SIZE ESTIMATION 45
FIGURE 5 HYPOTHESIS BUILDING 46
2.3 MARKET SIZE ESTIMATION METHODOLOGY 46
2.3.1 APPROACH 1: REVENUE SHARE ANALYSIS 46
FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION 47
2.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS 47
FIGURE 7 APPROACH 2: DEMAND SIDE ANALYSIS 48
2.3.3 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION 48
FIGURE 8 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION 49
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET: CAGR PROJECTION ANALYSIS 50
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 52
FIGURE 11 DATA TRIANGULATION METHODOLOGY 52
2.5 STUDY ASSUMPTIONS 53
2.6 RISK ASSESSMENT 54
TABLE 1 RISK ASSESSMENT ANALYSIS 54
2.7 LIMITATIONS 54
2.7.1 SCOPE-RELATED LIMITATIONS 54
2.7.2 METHODOLOGY-RELATED LIMITATIONS 54
2.8 RECESSION IMPACT ANALYSIS 54
3 EXECUTIVE SUMMARY 56
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 56
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 57
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2023 VS. 2028 (USD MILLION) 58
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 59
FIGURE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2023 VS. 2028 (USD MILLION) 60
FIGURE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION) 61
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF CLINICAL DECISION SUPPORT SYSTEMS MARKET 62
4 PREMIUM INSIGHTS 63
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW 63
FIGURE 21 INCREASING GOVERNMENT REGULATIONS FOR IMPLEMENTATION OF HCIT SOLUTIONS TO DRIVE MARKET 63
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY 64
FIGURE 22 INTEGRATED CDSS SEGMENT DOMINATED US MARKET IN 2022 64
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 64
FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 64
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL MIX 65
FIGURE 24 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 65
4.5 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES 65
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 65
 
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing government regulations for implementation of HCIT solutions 67
5.2.1.2 Growing adoption of CDSS-enabled EHRs 68
5.2.1.3 Rising incidence of medication errors 69
5.2.2 RESTRAINTS 69
5.2.2.1 Data security concerns in cloud-based CDSS 69
5.2.2.2 Inadequate interoperability for patient management solutions 69
5.2.3 OPPORTUNITIES 70
5.2.3.1 Development of big data and mHealth tools 70
5.2.3.2 High growth potential of emerging economies 70
5.2.3.3 Rising technological advancements 71
5.2.4 CHALLENGES 72
5.2.4.1 High capital investments for CDSS infrastructure 72
5.2.4.2 Shortage of skilled IT professionals 72
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 27 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR CLINICAL DECISION SUPPORT SYSTEMS MARKET 72
5.4 VALUE CHAIN ANALYSIS 73
FIGURE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE CHAIN ANALYSIS 73
5.5 CASE STUDY ANALYSIS 73
5.5.1 IMPROVING PATIENT OUTCOMES 73
TABLE 2 CASE 1: RISING FOCUS ON IMPROVING PATIENT SAFETY 73
5.5.2 KNOWLEDGE ANALYZER DELIVERS ADVANCED CLINICAL EXPERIENCE 74
TABLE 3 CASE 2: RISING NEED TO STREAMLINE PATIENT OUTCOMES 74
5.5.3 ENHANCING PHYSICIAN EFFICIENCY 74
TABLE 4 CASE 3: RISING NEED TO IMPROVE RESPONSE TIME AND PHYSICIAN EFFICIENCY IN HEALTHCARE FACILITIES 74
5.5.4 INCREASING EFFICIENCY AND HEALTHCARE OUTCOMES WITH AI 75
TABLE 5 CASE 4: RISING FOCUS ON ENHANCING EFFICIENCY AND VALUE-BASED CARE WITH AI-POWERED CDSS 75
5.6 ECOSYSTEM ANALYSIS 75
FIGURE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECOSYSTEM ANALYSIS 75
5.7 TECHNOLOGY ANALYSIS 76
TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 76
5.8 TARIFF AND REGULATORY ANALYSIS 78
5.8.1 TARIFF FOR CDSS HARDWARE 78
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
5.8.3 NORTH AMERICA 82
5.8.3.1 Federal Food, Drug, and Cosmetic Act (FD&C Act) 82
5.8.3.2 Health Insurance Portability and Accountability Act (HIPAA) 83
5.8.3.3 Affordable Care Act, 2010 83
5.8.3.4 Health Information Technology for Economic and Clinical Health Act, 2009 (HITECH) 83
5.8.3.5 Consumer Privacy Protection Act, 2017 83
5.8.4 EUROPE 84
5.8.4.1 General Data Protection Regulation (GDPR), European Union (EU) 84
5.8.4.2 EU Cybersecurity Act 84
5.8.5 ASIA PACIFIC 84
5.8.5.1 China’s Cyber Security Law (CSL) 84
5.8.6 REST OF THE WORLD 84
5.8.6.1 Protection of Personal Information Act 84
5.8.6.2 Private cloud computing regulatory framework 84
5.9 PORTER’S FIVE FORCES ANALYSIS 85
TABLE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 85
5.9.1 THREAT OF NEW ENTRANTS 85
5.9.2 THREAT OF SUBSTITUTES 85
5.9.3 BARGAINING POWER OF SUPPLIERS 86
5.9.4 BARGAINING POWER OF BUYERS 86
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.10 INDUSTRY TRENDS 86
5.10.1 GROWING APPLICATIONS OF AI IN CDSS 86
5.10.2 INCREASING FOCUS ON MOBILE & CLOUD-BASED SOLUTIONS 87
5.10.3 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS 87
5.10.4 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS 88
5.10.5 INCREASING DEMAND FOR VALUE-BASED HEALTHCARE 88
5.11 BUSINESS MODELS 89
FIGURE 30 BENEFITS OF HYBRID BUSINESS MODELS 90
5.12 PRICING ANALYSIS 90
5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 90
FIGURE 31 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 91
5.12.2 AVERAGE SELLING PRICE TREND, BY REGION 91
TABLE 12 AVERAGE SELLING PRICE TREND, BY REGION 92
5.13 PATENT ANALYSIS 92
5.13.1 PATENT PUBLICATION TRENDS FOR CLINICAL DECISION SUPPORT SYSTEMS 92
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023) 93
5.13.2 INSIGHTS INTO JURISDICTION AND TOP APPLICANT ANALYSIS 93
FIGURE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2011–AUGUST 2023) 94
5.13.3 LIST OF PATENTS/PATENT APPLICATIONS FOR CDSS 94
5.14 KEY CONFERENCES AND EVENTS 96
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS: DETAILED LIST OF CONFERENCES AND EVENTS (2023–2024) 96
5.15 TRADE ANALYSIS 96
5.15.1 TRADE ANALYSIS FOR CLINICAL DECISION SUPPORT SYSTEM HARDWARE 96
FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND) 97
FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND) 97
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 98
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 98
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%) 98
5.16.2 BUYING CRITERIA 99
FIGURE 37 CLINICAL DECISION SUPPORT SYSTEMS: KEY BUYING CRITERIA, BY COMPONENT 99
TABLE 15 BUYING CRITERIA FOR COMPONENTS, BY RANK 99
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT 100
6.1 INTRODUCTION 101
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 101
6.2 SERVICES 101
6.2.1 RECURRING REQUIREMENT TO DRIVE MARKET 101
TABLE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.3 SOFTWARE 103
6.3.1 USE OF EMR-/EHR-INTEGRATED CDSS TO PROPEL MARKET 103
TABLE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.4 HARDWARE 104
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH 104
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 104
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT 105
7.1 INTRODUCTION 106
TABLE 20 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 106
7.2 INTEGRATED CDSS 106
7.2.1 INTEGRATION WITH EHRS AND RAPID ACCESS TO PATIENT RECORDS TO DRIVE MARKET 106
TABLE 21 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
7.3 STANDALONE CDSS 108
7.3.1 INTEROPERABILITY ISSUES WITH CPOE AND EHR TO RESTRAIN MARKET 108
TABLE 22 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE 109
8.1 INTRODUCTION 110
TABLE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
8.2 THERAPEUTIC CDSS 110
8.2.1 SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS TO DRIVE MARKET 110
TABLE 24 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.3 DIAGNOSTIC CDSS 111
8.3.1 USE OF ALGORITHMS FOR EFFECTIVE REAL-TIME DIAGNOSIS TO SUPPORT MARKET GROWTH 111
TABLE 25 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL 113
9.1 INTRODUCTION 114
TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 114
9.2 KNOWLEDGE-BASED CDSS 114
9.2.1 DEPLOYS CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS 114
TABLE 27 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
9.3 NON-KNOWLEDGE-BASED CDSS 115
9.3.1 IMPLEMENTS ML AND AI TO EXPAND USER-DEFINED KNOWLEDGE BASE 115
TABLE 28 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE 117
10.1 INTRODUCTION 118
TABLE 29 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 118
10.2 ON-PREMISE CDSS 118
10.2.1 LOWER RISK OF DATA BREACH AND ABILITY TO CHOOSE MULTIPLE VENDORS TO DRIVE MARKET 118
TABLE 30 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
10.3 CLOUD-BASED CDSS 119
10.3.1 FLEXIBLE AND SCALABLE FEATURES TO PROPEL MARKET 119
TABLE 31 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION 121
11.1 INTRODUCTION 122
TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
11.2 CONVENTIONAL CDSS 122
11.2.1 ABILITY TO PROVIDE DIAGNOSTIC ASSISTANCE AND PRESCRIPTION DECISION SUPPORT TO DRIVE MARKET 122
TABLE 33 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
11.3 ADVANCED CDSS 123
11.3.1 REAL-TIME EVIDENCE AND PROTOCOL VALIDATION BENEFITS TO PROPEL MARKET 123
TABLE 34 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL 125
12.1 INTRODUCTION 126
TABLE 35 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 126
12.2 ACTIVE CDSS 126
12.2.1 ABILITY TO ENABLE OPTIMAL DECISION-MAKING WITH MINIMAL ERRORS TO DRIVE MARKET 126
TABLE 36 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
12.3 PASSIVE CDSS 127
12.3.1 MINIMAL DISRUPTION TO WORKFLOWS TO SUPPORT MARKET GROWTH 127
TABLE 37 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING 129
13.1 INTRODUCTION 130
TABLE 38 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 130
13.2 INPATIENT SETTINGS 130
13.2.1 GROWING FOCUS ON IMPROVING HEALTHCARE OPERATIONS IN HOSPITALS TO PROPEL MARKET 130
TABLE 39 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 131
13.3 AMBULATORY CARE SETTINGS 131
13.3.1 RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET 131
TABLE 40 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 132
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION 133
14.1 INTRODUCTION 134
TABLE 41 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
14.2 NORTH AMERICA 134
FIGURE 38 NORTH AMERICA: CDSS MARKET SNAPSHOT 135
TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 136
TABLE 44 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 136
TABLE 45 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 46 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 47 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 137
TABLE 48 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 137
TABLE 49 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 50 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 138
14.2.1 US 138
14.2.1.1 Growing focus on value-based care to drive market 138
TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 139
TABLE 52 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 140
TABLE 53 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
TABLE 54 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 55 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 141
TABLE 56 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 141
TABLE 57 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141
TABLE 58 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 142
14.2.2 CANADA 142
14.2.2.1 Rising need to curb healthcare costs to propel market 142
TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 143
TABLE 60 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 143
TABLE 61 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 143
TABLE 62 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 63 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 144
TABLE 64 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 144
TABLE 65 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 66 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 145
14.2.3 NORTH AMERICA: RECESSION IMPACT 145
14.3 EUROPE 146
TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 146
TABLE 69 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 147
TABLE 70 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
TABLE 71 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 72 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 148
TABLE 73 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 148
TABLE 74 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 75 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 149
14.3.1 GERMANY 149
14.3.1.1 Favorable government support for adoption of EMRs to propel market 149
TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 150
TABLE 77 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 150
TABLE 78 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 150
TABLE 79 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 80 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 151
TABLE 81 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 151
TABLE 82 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 83 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 152
14.3.2 UK 152
14.3.2.1 Rising establishment of healthcare facilities to fuel market 152
TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 153
TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 153
TABLE 86 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 87 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 88 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 154
TABLE 89 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 155
TABLE 90 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 91 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 155
14.3.3 FRANCE 156
14.3.3.1 Robust interoperability for EHR systems to drive market 156
TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 156
TABLE 93 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 157
TABLE 94 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 95 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 96 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 158
TABLE 97 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 158
TABLE 98 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 99 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 159
14.3.4 ITALY 159
14.3.4.1 Rising need for evidence-based CDSS to drive market 159
TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 159
TABLE 101 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 160
TABLE 102 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 103 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 104 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 161
TABLE 105 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 161
TABLE 106 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 107 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 162
14.3.5 SPAIN 162
14.3.5.1 Growing focus on improving patient outcomes to support market growth 162
TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 162
TABLE 109 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 163
TABLE 110 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 163
TABLE 111 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 112 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 164
TABLE 113 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 164
TABLE 114 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 164
TABLE 115 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 165
14.3.6 REST OF EUROPE 165
TABLE 116 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 165
TABLE 117 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 166
TABLE 118 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 119 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 120 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 167
TABLE 121 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 167
TABLE 122 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 123 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 168
14.3.7 EUROPE: RECESSION IMPACT 168
14.4 ASIA PACIFIC 169
FIGURE 39 ASIA PACIFIC: CDSS MARKET SNAPSHOT 170
TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 171
TABLE 126 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 171
TABLE 127 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 128 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 129 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 172
TABLE 130 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 172
TABLE 131 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 132 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 173
14.4.1 JAPAN 173
14.4.1.1 Rising need to digitize patient records to propel market 173
TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 174
TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 174
TABLE 135 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 136 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 137 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 175
TABLE 138 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 175
TABLE 139 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 140 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 176
14.4.2 CHINA 176
14.4.2.1 Established healthcare reforms for EMR solutions to drive market 176
TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 177
TABLE 142 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 177
TABLE 143 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 144 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 145 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 178
TABLE 146 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 179
TABLE 147 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 148 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 179
14.4.3 INDIA 180
14.4.3.1 Rising adoption of telemedicine to support market growth 180
TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 180
TABLE 150 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 180
TABLE 151 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 181
TABLE 152 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 153 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 181
TABLE 154 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 182
TABLE 155 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 156 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 182
14.4.4 REST OF ASIA PACIFIC 183
TABLE 157 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 183
TABLE 158 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 184
TABLE 159 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184
TABLE 160 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 161 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 185
TABLE 162 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 185
TABLE 163 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 164 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 186
14.4.5 ASIA PACIFIC: RECESSION IMPACT 186
14.5 REST OF THE WORLD 186
TABLE 165 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 186
TABLE 166 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 187
TABLE 167 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 187
TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 187
TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 188
TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 188
TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189
TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 189
14.5.1 LATIN AMERICA 189
14.5.1.1 Developments in healthcare infrastructure to support market growth 189
TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 190
TABLE 175 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 190
TABLE 176 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 177 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 178 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 191
TABLE 179 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 191
TABLE 180 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 181 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 192
14.5.2 MIDDLE EAST & AFRICA 192
14.5.2.1 Increasing investments in HCIT solutions to propel market 192
TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 193
TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION) 193
TABLE 184 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 193
TABLE 185 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 186 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION) 194
TABLE 187 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION) 194
TABLE 188 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 195
TABLE 189 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION) 195
14.5.3 REST OF THE WORLD: RECESSION IMPACT 195
15 COMPETITIVE LANDSCAPE 196
15.1 OVERVIEW 196
15.2 STRATEGIES ADOPTED BY KEY PLAYERS 196
TABLE 190 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 197
15.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS 198
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS 198
15.4 MARKET SHARE ANALYSIS 199
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 199
15.5 COMPANY EVALUATION MATRIX 200
15.5.1 STARS 200
15.5.2 EMERGING LEADERS 201
15.5.3 PERVASIVE PLAYERS 201
15.5.4 PARTICIPANTS 201
15.5.5 COMPANY FOOTPRINT 201
TABLE 191 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY FOOTPRINT OF KEY PLAYERS 201
TABLE 192 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS 202
TABLE 193 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS 202
FIGURE 42 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATION MATRIX (2022) 203
15.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 204
15.6.1 PROGRESSIVE COMPANIES 204
15.6.2 RESPONSIVE COMPANIES 204
15.6.3 DYNAMIC COMPANIES 204
15.6.4 STARTING BLOCKS 204
FIGURE 43 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 205
15.6.4.1 COMPETITIVE BENCHMARKING 206
TABLE 194 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 206
TABLE 195 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES) 207
15.7 COMPETITIVE SITUATIONS AND TRENDS 207
TABLE 196 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (JANUARY 2020–AUGUST 2023) 208
15.7.1 DEALS 210
TABLE 197 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEALS (JANUARY 2020–AUGUST 2023) 210
15.7.2 OTHER DEVELOPMENTS 212
TABLE 198 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023) 212

16 COMPANY PROFILES 214
16.1 KEY PLAYERS 214
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1 EPIC SYSTEMS CORPORATION 214
TABLE 199 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 214
16.1.2 WOLTERS KLUWER N.V. 217
TABLE 200 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW 217
FIGURE 44 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2022) 218
16.1.3 ORACLE 222
TABLE 201 ORACLE: BUSINESS OVERVIEW 222
FIGURE 45 ORACLE: COMPANY SNAPSHOT (2023) 223
16.1.4 MERATIVE 226
TABLE 202 MERATIVE: BUSINESS OVERVIEW 226
16.1.5 VERADIGM LLC 229
TABLE 203 VERADIGM LLC: BUSINESS OVERVIEW 229
FIGURE 46 VERADIGM LLC: COMPANY SNAPSHOT (2021) 230
16.1.6 CHANGE HEALTHCARE (PART OF OPTUM) 235
FIGURE 47 OPTUM.: COMPANY SNAPSHOT (2022) 235
16.1.7 ATHENAHEALTH 239
TABLE 205 ATHENA HEALTH: BUSINESS OVERVIEW 239
16.1.8 ELSEVIER (DIVISION OF RELX GROUP) 242
TABLE 206 ELSEVIER: BUSINESS OVERVIEW 242
16.1.9 ZYNX HEALTH INCORPORATED 244
TABLE 207 ZYNX HEALTH INCORPORATED: BUSINESS OVERVIEW 244
16.1.10 KONINKLIJKE PHILIPS N.V. 247
TABLE 208 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 247
FIGURE 48 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 248
16.1.11 MEDICAL INFORMATION TECHNOLOGY, INC. 251
TABLE 209 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW 251
16.1.12 NEXTGEN HEALTHCARE, INC. 254
TABLE 210 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW 254
FIGURE 49 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2022) 254
16.1.13 CUREMD HEALTHCARE 257
TABLE 211 CUREMD HEALTHCARE: BUSINESS OVERVIEW 257
16.1.14 SIEMENS HEALTHINEERS 260
TABLE 212 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 260
FIGURE 50 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 261
16.1.15 EBSCO INFORMATION SERVICES 263
TABLE 213 EBSCO INFORMATION SERVICES: BUSINESS OVERVIEW 263
16.1.16 GE HEALTHCARE 268
TABLE 214 GE HEALTHCARE: BUSINESS OVERVIEW 268
FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 269
16.1.17 ECLINICALWORKS, LLC 271
TABLE 215 ECLINICALWORKS, LLC: BUSINESS OVERVIEW 271
16.1.18 THE MEDICAL ALGORITHMS COMPANY LIMITED 274
TABLE 216 THE MEDICAL ALGORITHMS COMPANY LIMITED: BUSINESS OVERVIEW 274
16.1.19 HERA-MI 275
TABLE 217 HERA-MI: BUSINESS OVERVIEW 275
16.1.20 RAMPMEDICAL 276
TABLE 218 RAMPMEDICAL: BUSINESS OVERVIEW 276
16.2 OTHER PLAYERS 277
16.2.1 CARECLOUD, INC. 277
16.2.2 VISUALDX 277
16.2.3 STANSON HEALTH (PART OF PREMIER, INC.) 278
16.2.4 FIRST DATABANK, INC. 278
16.2.5 STRATA DECISION TECHNOLOGY 279
16.2.6 ALCIDION 280
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX 281
17.1 DISCUSSION GUIDE 281
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 285
17.3 CUSTOMIZATION OPTIONS 287
17.4 RELATED REPORTS 287
17.5 AUTHOR DETAILS 288